查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529789

全球个人化医疗外包市场：市场规模、份额、趋势分析 - 按阶段、按应用、按服务、按类型、按最终用途、按地区、细分市场预测，2024-2030 年

Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Clinical, Preclinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

预计2023年全球个人化医疗外包市场规模将达1,016.2亿美元，2024年至2030年复合年增长率为12.21%。

人们对个人化医疗益处的认识不断提高，个人化医疗在罕见疾病、癌症和感染疾病，对专业知识的需求以及外包服务的好处这些是推动市场的主要因素。生长。

慢性病、罕见疾病和感染疾病的盛行率不断上升，进一步增加了对这些药物的需求，以改善患者的治疗效果。美国癌症协会公布的资料显示，2023年美国将有约609,820人死于癌症。

个人化医疗在癌症治疗的应用显着增加，这是市场成长的关键驱动力之一。个人化医疗或精准医疗在肿瘤学中有多种用途，包括早期检测某些癌症、识别癌症高风险族群、评估治疗方案以及治疗对患者健康的影响。随着此类疾病负担的增加，对个人化医疗的需求也预计会增加。

此外，随着许多製药公司选择将药物开发和製造活动委託给这些外包公司，CRO 和 CDMO 在过去几年中经历了显着成长。建立和维护个人化医疗从开发到製造各个方面的内部能力需要多种资源和投资。因此，外包这些活动为公司提供了根据其需求量身定制的专业知识、基础设施和资源，使他们能够提供具有成本效益的解决方案。此外，与开发个人化解决方案相关的复杂性和风险（例如临床前和临床阶段的失败）是重要的风险因素，而 CRO 可以处理复杂的后期开发和製造，使公司业务简化流程并提高效率。

近年来，个人化医疗因其多种好处而获得了广泛认可，包括减少试验错、帮助避免副作用以及将医学重点从预防转向应对。个人化医疗提供了使用分子标记的能力，甚至可以在临床症状或体征出现之前指示疾病的风险或存在，从而可以及早治疗疾病，从而改善患者的治疗效果。

同样，患者不遵守所提供的治疗或药物可能会导致药物不良反应 (ADR) 等负面健康影响。因此，ADR病例的增加将增加人口对更好治疗选择的需求，进一步增加对个人化医疗的需求。例如，根据美国国立卫生美国（NIH）2024年1月发表的论文，2022年美国将出现约125万例严重副作用病例，约17.5万人死亡。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章个人化医疗外包市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
  • 市场分析工具

第四章个人化医疗外包市场：逐步估算与趋势分析

  • 细分仪表板
  • 全球个人化医疗外包市场相变分析
  • 2018-2030年全球个人化医疗外包市场规模及趋势分析（分阶段）
  • 临床
  • 临床前

第五章个人化医疗外包市场：应用预估与趋势分析

  • 细分仪表板
  • 全球个人化医疗外包市场应用变迁分析
  • 2018-2030年全球个人化医疗外包市场规模及趋势分析（按应用）
  • 肿瘤学
  • 罕见疾病
  • 感染疾病
  • 其他的

第六章个人化医疗外包市场：服务评估与趋势分析

  • 细分仪表板
  • 全球个人化医疗外包市场服务波动分析
  • 2018-2030年全球个人化医疗外包市场规模及趋势分析（按服务）
  • 契约製造
  • 合约开发

第七章个人化医疗外包市场：类型估算与趋势分析

  • 细分仪表板
  • 全球个人化医疗外包市场类型变异分析
  • 2018-2030年全球个人化医疗外包市场规模及趋势分析（按类型）
  • 抑制剂
  • 单株抗体
  • 细胞/基因治疗
  • 其他的

第八章个人化医疗外包市场：最终用途估计与趋势分析

  • 细分仪表板
  • 全球个人化医疗外包市场的最终用途变化分析
  • 2018-2030年全球个人化医疗外包市场规模及趋势分析（依最终用途）
  • 製药公司
  • 生技公司
  • 其他的

第九章个人化医疗外包市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 2018-2030 年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030 年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030 年中东和非洲市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • Parexel International（MA）Corporation
    • Syneos Health
    • Catalent, Inc
    • ICON
    • Lonza
    • Syngene International Limited
    • HCL Technologies Limited
    • Infosys Limited
    • Fujirebio
    • Aurigene Pharmaceutical Services Ltd.
Product Code: GVR-4-68040-350-7

Market Size & Trends

The global personalized medicine outsourcing market size was estimated at USD 101.62 billion in 2023 and is projected to grow at a CAGR of 12.21% from 2024 to 2030. The increasing awareness about the benefits of personalized medicine, increasing application of personalized medicine in various diseases, such as rare diseases, cancer, infectious diseases, and others, the requirement of specialized expertise, and the benefits of outsourcing the services are some of the major factors driving the market growth.

The increasing prevalence of diseases such as chronic diseases, rare diseases and infectious diseases is further increasing the demand for these medicines as it offers enhanced patient outcomes. According to the data published by American Cancer Society, cancer was expected to cause around 609,820 deaths in the U.S. in 2023 and was expected to diagnose over 1.9 people in the same year.

The applications of personalized medicine have significantly increased in cancer care, which is one of the major factors contributing to the market growth. Personalized medicine or precision medicine is utilized for several purposes in oncology such as early detection of certain cancers, identifying people with higher cancer risk, evaluation of treatment alternatives, and effect of treatment on patient's health. As the burden of these diseases increase, the demand for personalized medicine is also anticipated to witness growth.

Furthermore, CROs and CDMOs have witnessed significant growth during the past few years as most of the pharmaceutical companies are opting to outsource their drug development and manufacturing activities to these outsourcing companies. Building and maintaining internal capabilities for all aspects of personalized medicine, from development to manufacturing, requires several resources and investments. Therefore, outsourcing these activities can allow companies to access specialized expertise, infrastructure, and resources according to their needs, thereby offering a cost-effective solution. Moreover, the complexity and risk associated with the development of personalized solutions, such as failures in the preclinical and clinical phases, offer a significant risk factor, while CROs can handle the complexities of later-stage development and manufacturing, allowing companies to streamline their operations and enhance their efficiency.

The awareness about personalized medicine has significantly increased in recent years owing to its several benefits, such as reducing trial and error prescribing, helping in avoiding adverse drug reactions, and shifting the medical emphasis from prevention to reaction. Personalized medicine offers the ability to use molecular markers that can indicate the disease risk or presence even before clinical signs and symptoms appear, allowing for early treatments of diseases and thereby improving patient outcomes.

Similarly, the patient's non-compliance with offered treatment and medication can lead to adverse health effects such as Adverse Drug Reactions (ADR), which have been on a significant rise in past years. Thus, increasing cases of ADRs would boost the demand for better treatment options among people further driving the demand for personalized medicine. For instance, according to an article published by the National Institute of Health (NIH) in January 2024, there were around 1.25 million serious adverse effects and approximately 175,000 deaths were recorded in the U.S. in 2022.

Global Personalized Medicine Outsourcing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global personalized medicine outsourcing market report based on phase, application, service, type, end-use, and region.

  • Phase Outlook (Revenue, USD Million, 2018 - 2030)
  • Clinical

Phase I

Phase II

Phase III

Phase IV

  • Preclinical
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology
  • Rare Diseases
  • Infectious Diseases
  • Others
  • Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Contract Manufacturing
  • Contact Development
  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Inhibitor Drugs
  • Monoclonal Antibodies
  • Cell & Gene Therapy
  • Other Therapeutic Products
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Mexico

Argentina

  • MEA

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Phase Segment
    • 1.2.2. Application Segment
    • 1.2.3. Service Segment
    • 1.2.4. Type Segment
    • 1.2.5. End use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Personalized Medicine Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic and rare diseases
      • 3.2.1.2. Increasing awareness about the benefits of personalized medicine
      • 3.2.1.3. Increasing application of personalized medicine in various diseases
      • 3.2.1.4. Requirement of specialized expertise for personalized medicine development and manufacturing
    • 3.2.2. Market restraints analysis
      • 3.2.2.1. Data Privacy Concerns
  • 3.3. Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Personalized Medicine Outsourcing Market: Phase Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Personalized Medicine Outsourcing Market Phase Movement Analysis
  • 4.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Phase, 2018 to 2030 (USD Million)
  • 4.4. Clinical
    • 4.4.1. Clinical market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Phase I
      • 4.4.2.1. Phase I market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Phase II
      • 4.4.3.1. Phase II market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Phase III
      • 4.4.4.1. Phase III market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Phase IV
      • 4.4.5.1. Phase IV market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Preclinical
    • 4.5.1. Preclinical market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Personalized Medicine Outsourcing Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Personalized Medicine Outsourcing Market Application Movement Analysis
  • 5.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Rare Diseases
    • 5.5.1. Rare Diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Infectious Diseases
    • 5.6.1. Infectious Diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Personalized Medicine Outsourcing Market: Service Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Personalized Medicine Outsourcing Market Service Movement Analysis
  • 6.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 6.4. Contract Manufacturing
    • 6.4.1. Contract Manufacturing market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Contact Development
    • 6.5.1. Contact Development market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Personalized Medicine Outsourcing Market: Type Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Personalized Medicine Outsourcing Market Type Movement Analysis
  • 7.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 7.4. Inhibitor Drugs
    • 7.4.1. Inhibitor Drugs market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Monoclonal Antibodies
    • 7.5.1. Monoclonal Antibodies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Cell & Gene Therapy
    • 7.6.1. Cell & Gene Therapy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Personalized Medicine Outsourcing Market: End use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Personalized Medicine Outsourcing Market End use Movement Analysis
  • 8.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
  • 8.4. Pharmaceutical Companies
    • 8.4.1. Pharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Biotechnology Companies
    • 8.5.1. Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Personalized Medicine Outsourcing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. Target disease prevalence
      • 9.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. Target disease prevalence
      • 9.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. Target disease prevalence
      • 9.4.4.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. Target disease prevalence
      • 9.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. Target disease prevalence
      • 9.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. Target disease prevalence
      • 9.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. Target disease prevalence
      • 9.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Target disease prevalence
      • 9.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Competitive scenario
      • 9.5.7.3. Regulatory framework
      • 9.5.7.4. Target disease prevalence
      • 9.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Competitive scenario
      • 9.5.8.3. Regulatory framework
      • 9.5.8.4. Target disease prevalence
      • 9.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.9. Denmark
      • 9.5.9.1. Key country dynamics
      • 9.5.9.2. Competitive scenario
      • 9.5.9.3. Regulatory framework
      • 9.5.9.4. Target disease prevalence
      • 9.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Target disease prevalence
      • 9.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Competitive scenario
      • 9.6.3.3. Regulatory framework
      • 9.6.3.4. Target disease prevalence
      • 9.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Competitive scenario
      • 9.6.4.3. Regulatory framework
      • 9.6.4.4. Target disease prevalence
      • 9.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Competitive scenario
      • 9.6.5.3. Regulatory framework
      • 9.6.5.4. Target disease prevalence
      • 9.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Competitive scenario
      • 9.6.6.3. Regulatory framework
      • 9.6.6.4. Target disease prevalence
      • 9.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Competitive scenario
      • 9.6.7.3. Target disease prevalence
      • 9.6.7.4. Regulatory framework
      • 9.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. Target disease prevalence
      • 9.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Target disease prevalence
      • 9.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Competitive scenario
      • 9.8.2.3. Regulatory framework
      • 9.8.2.4. Target disease prevalence
      • 9.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Competitive scenario
      • 9.8.3.3. Regulatory framework
      • 9.8.3.4. Target disease prevalence
      • 9.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Competitive scenario
      • 9.8.4.3. Regulatory framework
      • 9.8.4.4. Target disease prevalence
      • 9.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key country dynamics
      • 9.8.5.2. Competitive scenario
      • 9.8.5.3. Regulatory framework
      • 9.8.5.4. Target disease prevalence
      • 9.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2023
  • 10.4. Company Profiles/Listing
    • 10.4.1. Parexel International (MA) Corporation
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Syneos Health
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Catalent, Inc
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. ICON
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Lonza
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Syngene International Limited
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. HCL Technologies Limited
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Infosys Limited
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Fujirebio
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Aurigene Pharmaceutical Services Ltd.
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global personalized medicine outsourcing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 4 Global personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 6 Global personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 7 Global personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 8 North America personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 10 North America personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 12 North America personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 13 North America personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.S. personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 15 U.S. personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S. personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 17 U.S. personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 18 U.S. personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Canada personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 20 Canada personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 21 Canada personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 22 Canada personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 23 Canada personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Mexico personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 25 Mexico personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 26 Mexico personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 27 Mexico personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 28 Mexico personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Europe personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 31 Europe personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 32 Europe personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 33 Europe personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 34 Europe personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 36 Germany personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 37 Germany personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 38 Germany personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 39 Germany personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 UK personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 41 UK personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 42 UK personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 43 UK personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 44 UK personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 45 France personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 46 France personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 47 France personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 48 France personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 49 France personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Italy personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 51 Italy personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Italy personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 53 Italy personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 54 Italy personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Spain personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 56 Spain personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 57 Spain personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 58 Spain personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 59 Spain personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Denmark personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 61 Denmark personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 62 Denmark personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 63 Denmark personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 64 Denmark personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Sweden personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 66 Sweden personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 67 Sweden personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 68 Sweden personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 69 Sweden personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Norway personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 71 Norway personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 72 Norway personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 73 Norway personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 74 Norway personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 81 China personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 82 China personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 83 China personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 84 China personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 85 China personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Japan personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 87 Japan personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 88 Japan personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 89 Japan personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 90 Japan personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 91 India personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 92 India personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 93 India personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 94 India personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 95 India personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 96 South Korea personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 97 South Korea personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 98 South Korea personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 99 South Korea personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 100 South Korea personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Australia personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 102 Australia personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 103 Australia personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 104 Australia personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 105 Australia personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Thailand personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 107 Thailand personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 108 Thailand personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 109 Thailand personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 110 Thailand personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Latin America personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 113 Latin America personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 114 Latin America personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 115 Latin America personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 116 Latin America personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Brazil personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 118 Brazil personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 119 Brazil personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 120 Brazil personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 121 Brazil personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 122 Argentina personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 123 Argentina personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 124 Argentina personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 125 Argentina personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 126 Argentina personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 127 MEA personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 129 MEA personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 130 MEA personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 131 MEA personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 132 MEA personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 133 South Africa personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 134 South Africa personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 135 South Africa personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 136 South Africa personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 137 South Africa personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 143 UAE personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 144 UAE personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 145 UAE personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 146 UAE personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 147 UAE personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait personalized medicine outsourcing market, by phase, 2018 - 2030 (USD Million)
  • Table 149 Kuwait personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 150 Kuwait personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 151 Kuwait personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 152 Kuwait personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Personalized Medicine Outsourcing market: Market outlook
  • Fig. 5 Personalized Medicine Outsourcing market: Segment outlook
  • Fig. 6 Personalized Medicine Outsourcing market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Personalized Medicine Outsourcing market driver impact
  • Fig. 9 Personalized Medicine Outsourcing market restraint impact
  • Fig. 10 Personalized Medicine Outsourcing market: Phase outlook and key takeaways
  • Fig. 11 Personalized Medicine Outsourcing market: Phase movement analysis
  • Fig. 12 Preclinical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Phase I market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Phase II market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Phase III market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Phase IV market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Personalized Medicine Outsourcing market: Application outlook and key takeaways
  • Fig. 19 Personalized Medicine Outsourcing market: Application movement analysis
  • Fig. 20 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Rare Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Infectious Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Personalized Medicine Outsourcing market: Service outlook and key takeaways
  • Fig. 25 Personalized Medicine Outsourcing market: Service movement analysis
  • Fig. 26 Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Contact Development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Personalized Medicine Outsourcing market: Type outlook and key takeaways
  • Fig. 29 Personalized Medicine Outsourcing market: Type movement analysis
  • Fig. 30 Inhibitor Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Monoclonal Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cell & Gene Therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others
  • Fig. 34 Personalized Medicine Outsourcing market: End use outlook and key takeaways
  • Fig. 35 Personalized Medicine Outsourcing market: End use movement analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Pharmaceutical Companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Biotechnology Companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Global Laboratory Mixer market: Regional outlook and key takeaways
  • Fig. 40 Global Laboratory Mixer market: Regional movement analysis
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)